当前位置:首页 - 行情中心 - 川宁生物(301301) - 财务分析

川宁生物

(301301)

  

流通市值:67.96亿  总市值:245.31亿
流通股本:6.18亿   总股本:22.30亿

川宁生物(301301)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.55亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益778698.09万元,未分配利润191445.82万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1015930.43万元,负债237232.34万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,348,584,042.471,296,949,550.165,758,307,742.654,456,265,553.38
营业总成本1,753,026,754.01947,594,552.574,059,755,762.33,154,494,351.3
其他经营收益
营业利润575,431,246.56353,331,784.321,687,762,925.681,294,715,549.77
利润总额559,503,193.54350,002,745.911,675,091,839.311,277,922,127.14
净利润454,575,661.01288,206,596.521,400,350,219.971,075,957,079.13
每股收益
其他综合收益---99,338.34-
综合收益总额454,575,661.01288,206,596.521,400,250,881.631,075,957,079.13
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,916,481,272.984,416,378,924.564,144,223,873.544,088,077,855.64
非流动资产:
非流动资产合计6,242,823,019.616,316,164,332.276,409,356,087.636,463,298,638.29
资产总计10,159,304,292.5910,732,543,256.8310,553,579,961.1710,551,376,493.93
流动负债:
流动负债合计1,811,328,511.531,972,067,762.091,947,534,889.661,996,994,497.66
非流动负债:
非流动负债合计560,994,874.93553,278,437.67689,629,227.58965,170,787.4
负债合计2,372,323,386.462,525,346,199.762,637,164,117.242,962,165,285.06
所有者权益(或股东权益):
归属于母公司股东权益合计7,768,434,687.48,188,380,183.447,897,587,034.117,570,369,941.77
股东权益合计7,786,980,906.138,207,197,057.077,916,415,843.937,589,211,208.87
负债和股东权益合计10,159,304,292.5910,732,543,256.8310,553,579,961.1710,551,376,493.93
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,652,894,384.56648,163,490.344,783,112,022.393,165,660,715.72
经营活动现金流出小计1,261,410,616.16531,578,949.822,992,044,746.042,290,401,046.28
经营活动产生的现金流量净额391,483,768.4116,584,540.521,791,067,276.35875,259,669.44
投资活动产生的现金流量:
投资活动现金流入小计961,564,551.48200,464,358.91206,184,133.59201,145,426.03
投资活动现金流出小计1,006,564,070.41422,965,903.29312,401,377.78312,628,060.13
投资活动产生的现金流量净额-44,999,518.93-222,501,544.38-106,217,244.19-111,482,634.1
筹资活动产生的现金流量:
筹资活动现金流入小计12,935,5200806,191,920716,191,920
筹资活动现金流出小计639,692,901.2628,751,355.042,167,261,088.141,620,322,311.82
筹资活动产生的现金流量净额-626,757,381.26-28,751,355.04-1,361,069,168.14-904,130,391.82
汇率变动对现金及现金等价物的影响3,203,527.391,905,343.16,537,247.241,255,140.02
现金及现金等价物净增加额-277,069,604.4-132,763,015.8330,318,111.26-139,098,216.46
期末现金及现金等价物余额808,334,774.66952,641,363.261,088,331,674.61618,915,346.89
补充资料:
现金及现金等价物的净增加额-277,069,604.4-330,318,111.26-
TOP↑